Emerging optofluidic technologies for point-of-care genetic analysis systems: a review

2009 ◽  
Vol 395 (3) ◽  
pp. 621-636 ◽  
Author(s):  
Desmond Brennan ◽  
John Justice ◽  
Brian Corbett ◽  
Tommie McCarthy ◽  
Paul Galvin
2011 ◽  
Vol 133 (23) ◽  
pp. 9129-9135 ◽  
Author(s):  
B. Scott Ferguson ◽  
Steven F. Buchsbaum ◽  
Ting-Ting Wu ◽  
Kuangwen Hsieh ◽  
Yi Xiao ◽  
...  

2021 ◽  
Author(s):  
Faisal Iqbal ◽  
Muhammad Imran Shabbir

A DNA sequencer called LoopSeeq was developed using pyrosequencing chemistry where iterative addition of dNTPs was performed by contact dispensing through a loop pipette and detection of chemiluminescence with inexpensive light sensor LDR for point-of-care applications.


Lab on a Chip ◽  
2015 ◽  
Vol 15 (12) ◽  
pp. 2597-2605 ◽  
Author(s):  
Bowen Shu ◽  
Chunsun Zhang ◽  
Da Xing

An ultra-compact, battery-powered and easy-to-use microfluidic platform is proposed for rapid, sensitive, multiplex and real-time quantification and point-of-care genetic analysis.


2008 ◽  
Vol 54 (6) ◽  
pp. 1080-1084 ◽  
Author(s):  
Stephanie H I Yeung ◽  
Igor L Medintz ◽  
Susan A Greenspoon ◽  
Richard A Mathies

Abstract Background: Microfabricated genetic-analysis devices have great potential for delivering complex clinical diagnostic technology to the point of care. As a demonstration of the potential of these devices, we used a microfabricated capillary array electrophoresis (μCAE) instrument to rapidly characterize the familial and genotypic relationship of twins who had been assigned fraternal (dizygous) status at birth. Methods: We extracted the genomic DNA from buccal samples collected from the twin sons, the parents, another sibling, and an unrelated control individual. We then carried out multiplex PCR amplification of sequences at 16 short tandem repeat loci commonly used in forensic identity testing. We simultaneously separated the amplicons from all of the individuals on a μCAE device and fluorescently detected the amplicons with single-base resolution in <30 min. Results: The genotypic analysis confirmed the identical status of the twins and revealed, in conjunction with the medical data, that their twin status arose from the rarer dichorionic, diamniotic process. Conclusions: The ability to rapidly analyze complex genetic samples with μCAE devices demonstrates that this approach can help meet the growing need for rapid genetics-based diagnostics.


1997 ◽  
Vol 61 (6) ◽  
pp. 491-496 ◽  
Author(s):  
K. HIDAKA ◽  
I. IUCHI ◽  
M. TOMITA ◽  
Y. WATANABE ◽  
Y. MINATOGAWA ◽  
...  

Pathology ◽  
2003 ◽  
Vol 35 (2) ◽  
pp. 141-144 ◽  
Author(s):  
Hiroya Kato ◽  
Sukenari Koyabu ◽  
Shigenori Aoki ◽  
Takuya Tamai ◽  
Masahiro Sugawa ◽  
...  

VASA ◽  
2011 ◽  
Vol 40 (6) ◽  
pp. 429-438 ◽  
Author(s):  
Berent ◽  
Sinzinger

Based upon various platelet function tests and the fact that patients experience vascular events despite taking acetylsalicylic acid (ASA or aspirin), it has been suggested that patients may become resistant to the action of this pharmacological compound. However, the term “aspirin resistance” was created almost two decades ago but is still not defined. Platelet function tests are not standardized, providing conflicting information and cut-off values are arbitrarily set. Intertest comparison reveals low agreement. Even point of care tests have been introduced before appropriate validation. Inflammation may activate platelets, co-medication(s) may interfere significantly with aspirin action on platelets. Platelet function and Cox-inhibition are only some of the effects of aspirin on haemostatic regulation. One single test is not reliable to identify an altered response. Therefore, it may be more appropriate to speak about “treatment failure” to aspirin therapy than using the term “aspirin resistance”. There is no evidence based justification from either the laboratory or the clinical point of view for platelet function testing in patients taking aspirin as well as from an economic standpoint. Until evidence based data from controlled studies will be available the term “aspirin resistance” should not be further used. A more robust monitoring of factors resulting in cardiovascular events such as inflammation is recommended.


Sign in / Sign up

Export Citation Format

Share Document